down arrow

Gufic BioScience

Part of MojoOne Strategy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE742B01025
  • NSEID: GUFICBIO
  • BSEID: 509079
INR
322.15
8.85 (2.82%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 26.3 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

315.00327.95

52 Week

278.00501.10
Valuation
Technical
Day's Volume

CASH

26.3 k (-35.94%) Volume

Shareholding (Dec 2024)

FII

0.30%

Held by 21 FIIs

DII

2.98%

Held by 3 DIIs

Promoter

72.51%

iScoreScore
Part of MojoOne Strategy
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Negative results in Dec 24

  • OPERATING PROFIT TO INTEREST(Q) Lowest at 6.91 times
  • INTEREST(HY) At Rs 10.09 cr has Grown at 22.01%
  • PBDIT(Q) Lowest at Rs 33.92 cr.
2

Stock is technically in a Bearish range

3

With ROCE of 15.3, it has a Expensive valuation with a 4.1 Enterprise value to Capital Employed

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 3,230 Cr (Small Cap)

stock-summary
P/E

38.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.03%

stock-summary
Debt Equity

0.57

stock-summary
Return on Equity

15.40%

stock-summary
Price to Book

5.90

Revenue and Profits (1 Year):
Net Sales:
208 Cr
(Quarterly Results - Dec 2024)
Net Profit:
19 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.03%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-20.85%
0%
-20.85%
1 Year
3.84%
0.03%
3.87%
2 Years
69.91%
0.10%
70.01%
3 Years
29.98%
0.14%
30.12%
4 Years
180.01%
0.20%
180.21%
5 Years
399.07%
0.80%
399.87%

Latest dividend: 0.1 per share ex-dividend date: Sep-17-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
17.10%
EBIT Growth (5y)
26.12%
EBIT to Interest (avg)
11.14
Debt to EBITDA (avg)
1.99
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
2.18
Tax Ratio
25.97%
Dividend Payout Ratio
1.16%
Pledged Shares
0
Institutional Holding
3.29%
ROCE (avg)
27.06%
ROE (avg)
23.19%
Valuation key factors
Factor
Value
P/E Ratio
38
Industry P/E
33
Price to Book Value
5.90
EV to EBIT
27.56
EV to EBITDA
24.17
EV to Capital Employed
4.12
EV to Sales
4.25
PEG Ratio
NA
Dividend Yield
0.03%
ROCE (Latest)
15.31%
ROE (Latest)
15.40%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 6 Schemes (2.92%)

FIIs

Held by 21 FIIs (0.3%)

Promoter with highest holding

Jayesh Pannalal Choksi (24.62%)

Highest Public shareholder

Motilal Oswal Financial Services Ltd (3.32%)

Individual Investors Holdings

15.44%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 1.77% vs 0.68% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -11.29% vs 4.41% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "207.79",
          "val2": "204.18",
          "chgp": "1.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "33.94",
          "val2": "38.63",
          "chgp": "-12.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "4.91",
          "val2": "5.18",
          "chgp": "-5.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "19.32",
          "val2": "21.78",
          "chgp": "-11.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.33%",
          "val2": "18.92%",
          "chgp": "-2.59%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -0.71% vs 20.52% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -2.74% vs 6.23% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "406.99",
          "val2": "409.89",
          "chgp": "-0.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "74.40",
          "val2": "75.18",
          "chgp": "-1.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "9.80",
          "val2": "8.53",
          "chgp": "14.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "42.63",
          "val2": "43.83",
          "chgp": "-2.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.28%",
          "val2": "18.34%",
          "chgp": "-0.06%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 0.51% vs 18.18% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -6.26% vs 7.29% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "614.78",
          "val2": "611.67",
          "chgp": "0.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "108.34",
          "val2": "111.64",
          "chgp": "-2.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "14.71",
          "val2": "11.71",
          "chgp": "25.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "61.95",
          "val2": "66.09",
          "chgp": "-6.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.62%",
          "val2": "18.25%",
          "chgp": "-0.63%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 16.80% vs -11.36% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 8.08% vs -16.84% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "806.67",
          "val2": "690.62",
          "chgp": "16.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "145.54",
          "val2": "134.65",
          "chgp": "8.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "15.36",
          "val2": "8.22",
          "chgp": "86.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "86.14",
          "val2": "79.70",
          "chgp": "8.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.04%",
          "val2": "19.50%",
          "chgp": "-1.46%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
207.79
204.18
1.77%
Operating Profit (PBDIT) excl Other Income
33.94
38.63
-12.14%
Interest
4.91
5.18
-5.21%
Exceptional Items
0.00
0.00
Standalone Net Profit
19.32
21.78
-11.29%
Operating Profit Margin (Excl OI)
16.33%
18.92%
-2.59%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 1.77% vs 0.68% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is -11.29% vs 4.41% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
406.99
409.89
-0.71%
Operating Profit (PBDIT) excl Other Income
74.40
75.18
-1.04%
Interest
9.80
8.53
14.89%
Exceptional Items
0.00
0.00
Standalone Net Profit
42.63
43.83
-2.74%
Operating Profit Margin (Excl OI)
18.28%
18.34%
-0.06%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -0.71% vs 20.52% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is -2.74% vs 6.23% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
614.78
611.67
0.51%
Operating Profit (PBDIT) excl Other Income
108.34
111.64
-2.96%
Interest
14.71
11.71
25.62%
Exceptional Items
0.00
0.00
Standalone Net Profit
61.95
66.09
-6.26%
Operating Profit Margin (Excl OI)
17.62%
18.25%
-0.63%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 0.51% vs 18.18% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is -6.26% vs 7.29% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
806.67
690.62
16.80%
Operating Profit (PBDIT) excl Other Income
145.54
134.65
8.09%
Interest
15.36
8.22
86.86%
Exceptional Items
0.00
0.00
Standalone Net Profit
86.14
79.70
8.08%
Operating Profit Margin (Excl OI)
18.04%
19.50%
-1.46%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 16.80% vs -11.36% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 8.08% vs -16.84% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Gufic BioSciences Ltd stock-summary
stock-summary
Gufic BioSciences Ltd
Small Cap
Pharmaceuticals & Drugs
Gufic Biosciences (GBL) was incorporated in Jul'84. The Company is a result of a reverse merger of itself with Central Finance. The promoters of GBL took over Central Finance at Rs 40-42 per share and then got GBL listed on BSE. Presently, the Company is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Choksi and Gandhi family, the promoters of GBL, have a long-standing presence in the pharma industry.
Company Coordinates stock-summary
Company Details
Shop-37 1st Flr Kamala Bhavan, Swami Nityanand Road Andheri(E Mumbai Maharashtra : 400069
stock-summary
Tel: 91-022-66919187/67261007/66919189
stock-summary
http://www.gufic.com
stock-summary
info@guficbio.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."